Laryngeal Cancer Therapeutics – Pipeline Assessment and Market Forecasts to 2019

2012-02-28
Published : Feb-2012

GlobalData, the industry analysis specialist, has released its new report, “Laryngeal Cancer Therapeutics – Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Laryngeal Cancer Therapeutics market. The report identifies the key trends shaping and driving the global Laryngeal Cancer Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Laryngeal Cancer Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Laryngeal Cancer Therapeutics market. Its scope includes –

  • Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Laryngeal Cancer Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
  • Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
  • Analysis of the current and future competition in the seven key countries Laryngeal Cancer Therapeutics market.
  • Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
  • Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Laryngeal Cancer Therapeutics market.
  • Analysis of key recent licensing and partnership agreements in Laryngeal Cancer Therapeutics market

Laryngeal Cancer Therapeutics Market

Published:  February 2012
No.OF Pages: 70
Price: Single User License US$ 3995      Corporate User License US$ 11985

Request Sample

Table of Contents

1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6

2 Laryngeal Cancer Therapeutics – Introduction 7
2.1 Disease Overview 7
2.2 Epidemiology 8
2.3 Etiology and Risk Factors 9
2.4 Signs and Symptoms 9
2.5 Diagnosis 10
2.6 Staging (TNM Classification) 11
2.7 Treatment 14
2.7.1 Treatment by Stage of the Disease 15
2.7.2 Surgery 16
2.7.3 Radiation Therapy 16
2.7.4 Chemotherapy 17
2.7.5 Targeted Therapy 17
2.8 GlobalData Pipeline Report Guidance 21

3 Laryngeal Cancer Therapeutics – Market Characterization 22
3.1 Laryngeal Cancer Therapeutics Market Size (2006-2011) – Global 22
3.2 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) – Global 24
3.3 Laryngeal Cancer Therapeutics Market Size (2006-2011) – The US 26
3.4 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) – The US 27
3.5 Laryngeal Cancer Therapeutics Market Size (2006-2011) – The UK 28
3.6 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) – The UK 29
3.7 Laryngeal Cancer Therapeutics Market Size (2006-2011) – France 30
3.8 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) – France 31
3.9 Laryngeal Cancer Therapeutics Market Size (2006-2011) – Germany 32
3.10 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) – Germany 33
3.11 Laryngeal Cancer Therapeutics Market Size (2006-2011) – Italy 34
3.12 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) – Italy 35
3.13 Laryngeal Cancer Therapeutics Market Size (2006-2011) – Spain 36
3.14 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) – Spain 37
3.15 Laryngeal Cancer Therapeutics Market Size (2006-2011) – Japan 38
3.16 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) – Japan 39
3.17 Drivers and Barriers for Laryngeal Cancer Therapeutic Market 40
3.17.1 Drivers for the Laryngeal Cancer Therapeutics Market 40
3.17.2 Barriers for the Laryngeal Cancer Therapeutics Market 40
3.18 Key Events Impacting the Future Market 41
3.19 Opportunity and Unmet Need 42
3.20 Key Takeaway 43

4 Laryngeal Cancer Therapeutics Market – Competitive Assessment 44
4.1 Overview 44
4.1.1 Strategic Competitor Assessment 44
4.2 Laryngeal Cancer Therapeutics – Profile for Marketed Products 45
4.2.1 Erbitux (cetuximab) 45
4.2.2 Taxotere (docetaxel) 46
4.2.3 Bleomycin 47
4.3 Key Takeaway 48

5 Laryngeal Cancer Therapeutics Market – Pipeline Assessment 49
5.1 Overview 49
5.2 Strategic Pipeline Assessment 49
5.3 Laryngeal Cancer Pipeline Analysis – Pipeline by Phases of Development 50
5.3.1 Laryngeal Cancer Therapeutics – Phase III Pipeline 50
5.3.2 Laryngeal Cancer Therapeutics – Phase II Pipeline 51
5.3.3 Laryngeal Cancer Therapeutics – Phase I/II Pipeline 51
5.3.4 Laryngeal Cancer Therapeutics – Phase I Pipeline 51
5.4 Laryngeal Cancer Pipeline by Mechanism of Action 52
5.5 Laryngeal Cancer Technology Trends Analytical Framework 53
5.6 Laryngeal Cancer Therapeutics – Profile for Late Stage Molecules 54
5.6.1 Bevacizumab 54
5.6.2 Panitumumab 54
5.6.3 S-1 55
5.7 Key Takeaway 55

6 Laryngeal Cancer Therapeutics – Clinical Trials Mapping 56
6.1 Clinical Trials Mapping by Region/Country 56
6.2 Clinical Trials Mapping by Phase 57
6.3 Clinical Trials Mapping by Trial Status 58
6.4 Clinical Trials Mapping by Overall Sponsors 59
6.5 Clinical Trial Mapping by Prominent Sponsors 60

7 Laryngeal Cancer Therapeutics – Strategic Assessment 61
7.1 Future Market Competition Scenario 61

8 Laryngeal Cancer Therapeutics – Future Players 62
8.1 Introduction 62
8.2 Company Profiles 62
8.2.1 Amgen Inc. 62

9 Global Laryngeal Cancer Therapeutics Market – Appendix 64
9.1 Definitions 64
9.2 Acronyms 64
9.3 Methodology 65
9.3.1 Coverage 66
9.3.2 Secondary Research 66
9.3.3 Forecasting 66
9.3.4 Primary Research 68
9.3.5 Expert Panel Validation 69
9.4 Contact Us 69
9.5 Disclaimer 69
9.6 Bibliography 69

List of Tables

List of Figures

Filed in: Pharmaceutical
Tags: 
More Reports
Title Price Buy Now

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027

“The ambulatory EHR market is projected to grow at a CAGR of 6.1% between 2022 and 2027.” The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concerns are some of the challenges that are expected to limit the growth of the market to a certain extent during the forecast period. “Cloud-based was the fastest-growing segment in the delivery mode of ambulatory EHR market in 2021” Cloud-based segment is projected to growth at the hi......
 $4950

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027

“The pharmaceutical excipients market growth can be attributed to factors such as the rising pharmaceuticals market, advancements in functional excipients, and the growing generics market. The rapidly growing biopharmaceuticals sector will also influence market growth..” The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period.The growth can be attributed to the expanding pharmaceutical industry which has fueled the drug production thereby increasing consumption rate for excipients. Additionally, factors like functional excipients development and upsurge in generics market is also likely to propel market growth. “The fillers & diluents functionality accounted for the larges......
 $

Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027

“Digital Pharmacy market to register a CAGR of 17.0%  during the forecasts period The digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population. However, patients relying on pharmacists for clinical support and increasing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period. “Over-the-counter (OTC) products segment is estimated  to grow at the highest rate during the forecast period” On the basis  ofdrug type, t......
 $4950

Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027

The pharmacy automation market is expected to grow at a CAGR of 7.9% in the forecast period. The pharmacy automation market is projected to reach USD 8.2 billion by 2027 from USD 5.6 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth in this market is attributed to the growing need to minimize medication errors, rapid decentralization of pharmacies, and growing focus on automation to reduce labor costs. However, the stringent regulations that delay product launches can inhibit the growth of this market. Based on product, the automated medication dispensing and storage systems segment holds the largest market share in 2021 Based on products, the pharmacy automation market is segmented into automated medication dispensing and storage systems, automated packagi......
 $4950

Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027

The topical drug delivery market is expected to grow at a CAGR of 8.9% in the forecast period. The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%. The growth of this market can largely be attributed to the high prevalence of topical prescription therapy for dry eye diseases,  growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, increase in prevalence of central nervous disorders,  rising preference for non-invasive drug delivery methods. “The semi-solid formulation segment accounted for the largest share of the topical drug delivery market, based on  product in 2021.” Based on products, the topical drug delivery the market is segmented into ......
 $4950

Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026

“Increasing incidence and prevalence of neurological disorders is a key factors driving growth in the cognition and memory enhancement market’’ The global cognition and memory enhancement market is projected to reach USD 38.9 billion by 2026 from USD 23.4 billion in 2021, at a CAGR of 10.7% during the forecast period. Elevating prevalence of neurological disorders, such as dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuroinfections, stroke, and cerebral palsy, have increased significantly over the years. “By product & service segment, the cognition & memory-enhancing drugs segment has registered fastest growth rate during the forecast period” Based on product & service, the cognition and memory en......
 $4950

High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027

The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others. “The innovative HPAPIs segment is expected to account for the largest share of the market in 2021” Based on type, the HPAPI market is segmented into innovative and generic. The innovative segment is expected to account for the largest share of the HPAPI market in 2021. The large share can be attributed to the increased R&D investments. “The Synthetic APIs segment to account for the largest share of the market in 2021” Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs. The synthetic AP......
 $4950

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027

“Increased risk of communicable diseases, Rising prevalence of bleeding disorders in global population, Use of Immunoglobulin’s for a range of neurological conditions, including multiple sclerosis, neuropathic pain, and chronic fatigue syndrome is expected to drive the overall growth of the plasma fractionation market.” The global plasma fractionation market size is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as rapid growth of geriatric population, growing prevalence of respiratory disorders such as alpha-1-antitrypsin deficiency (AATD) and emphysema, and use of plasma fractionation products as first-line therapies for a number of bleeding, hematological, an......
 $4950

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027

“Patient engagement solutions market to register a CAGR of 10.0% from 2022 to 2027” The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps. However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period. “Services segment is expected to grow at the highest rate......
 $4950

Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027

The global Healthcare cloud computing market is projected to reach USD 89.4  billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%. The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing, m health, wearlable devices, etc. “The healthcare provider solution was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due to COVID-19 is one of the key factors contributing to the growth of this segment. “Among end users, the healthcare providers segment ac......
 $4950
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy